The rapid and relentless spread of the 2019 coronavirus disease (COVID-19) pandemic elicits a safe and effective vaccine against the causative agent, coronavirus 2 (SARS-CoV-2). It...
Despite evidence of current crop efficacy of the vaccine used against coronavirus disease 2019 (COVID-19) in clinical trials and post-marketing surveillance data Effectiveness In the real...
In a recently published article in the journal cancer cell, Scientists have shown the incidence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in cancer...
In a recent study posted on medRxiv* Preprint server, researchers say that efforts to sequence the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) genome in Africa...
In a recent study posted on bioRxiv* Preprint server, researchers compared the efficiency of monovalent and bivalent messenger ribonucleic acid (mRNA) vaccines with severe acute respiratory...
In a recent survey published on the preprint server medRxiv *, Researchers will investigate the shelf life of the messenger ribonucleic acid (mRNA) -based coronavirus disease...
Recent Comments